| Authors: |
Friedrichs GS; Novartis Biomedical Research, 1 Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: greg.friedrichs@novartis.com., Abernathy MM; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA., Ackley D; Eli Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA., Clark M; Ability Biologics, 3 Place Ville-Marie Suite 400, Montréal, Québec H3B 4W8, Canada., DaSilva JK; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA., Foley CM; Abbvie Inc, North Chicago, IL, 60064, USA., Greiter-Wilke A; Roche Innovation Center Basel, Grenzacherstr. 124, CH 4070 Basel, Switzerland., Henderson KA; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA., Kremer JJ; Novartis BioMedical Research, 220 Massachusetts Avenue, Cambridge, MA 02139, USA., Morimoto BH; Alto Neuroscience, Inc. 369 S San Antonio Rd, Los Altos CA 94022, USA., Paglialunga S; Celerion, 2420 W Baseline Rd, Tempe, AZ 85283, USA., Pugsley MK; Cytokinetics, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA., Regan CP; Merck & Co., Inc., West Point, PA 19486, USA., Rossman EI; GSK, 1250 Collegeville Avenue, Collegeville, PA 19426, USA., Segretti JA; Abbvie Inc, North Chicago, IL, 60064, USA., Traebert M; Novartis BioMedical Research, Postfach, 4002 Basel, Switzerland., Vargas HM; Amgen Inc., Translational Safety & Bioanalytical Sciences, Thousand Oaks, CA 91320, USA., Wisialowski TA; Pfizer Research and Development, 445 Eastern Point Rd Groton, CT 06340, USA. |
